MWNA
GWPH

Marshall Wace North America’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Marshall Wace North America’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-7,154
Closed -$1.55M – 1968
2021
Q1 		$1.55M Buy
+7,154
New +$1.34M 0.01% 900
2020
Q3 		– Sell
-64,973
Closed -$7.97M – 1587
2020
Q2 		$7.97M Buy
64,973
+12,713
+24% +$1.44M 0.05% 298
2020
Q1 		$4.58M Sell
52,260
-100,255
-66% -$10.6M 0.03% 333
2019
Q4 		$15.9M Buy
152,515
+65,214
+75% +$7.31M 0.08% 227
2019
Q3 		$10M Sell
87,301
-378,761
-81% -$57.5M 0.06% 261
2019
Q2 		$80.3M Buy
466,062
+149,163
+47% +$25.8M 0.5% 49
2019
Q1 		$53.4M Buy
316,899
+297,858
+1,564% +$44.3M 0.38% 80
2018
Q4 		$1.85M Buy
+19,041
New +$2.5M 0.02% 441
2018
Q1 		– Sell
-105,250
Closed -$13.9M – 1807
2017
Q4 		$13.9M Buy
+105,250
New +$12.4M 0.08% 305

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Marshall Wace North America's GWPH Position: Q2 2021 in Review

Marshall Wace North America sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 7,154 shares — an estimated $1.55M sold.

Marshall Wace North America first reported a position in GWPH in Q4 2017 and held it in 9 quarters. The position peaked at $80.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Marshall Wace North America reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace North America sold 7,154 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.55M.
  • Marshall Wace North America first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2017 and held it in 9 quarters.
  • Marshall Wace North America's GW Pharmaceuticals Plc American Depositary Shares position peaked at $80.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.